Apolipoprotein E polymorphisms and mortality in Italian type 2 diabetic patients

Area of Science:

• Genetics and Cardiovascular Health
• Diabetes Research
• Epidemiology

Background:

• Apolipoprotein E (APOE) plays a role in lipid metabolism and has been implicated in cardiovascular disease.
• Type 2 diabetes is a significant risk factor for cardiovascular complications and mortality.
• Understanding genetic predispositions like APOE polymorphism in diabetic populations is crucial for risk stratification.

Purpose of the Study:

• To investigate the association between apolipoprotein E (APOE) polymorphism and mortality (cardiovascular and all-cause) in Italian patients with Type 2 diabetes.
• To identify primary determinants of premature mortality in this specific diabetic cohort.

Main Methods:

• A prospective cohort study involving 433 Italian Type 2 diabetic patients.
• APOE phenotype was assessed at baseline.
• Mortality data (cardiovascular and all-cause) were collected over a 10-year follow-up period.
• Univariate and multivariate analyses were employed.

Main Results:

• No significant association was found between APOE polymorphism and increased cardiovascular or all-cause mortality in Italian Type 2 diabetic patients.
• Age, duration of diabetes, and glycated hemoglobin (HbA1c) levels at study entry were identified as significant predictors of premature mortality.
• These findings held true in both univariate and multivariate analyses.

Conclusions:

• APOE polymorphisms are not reliable markers for predicting premature mortality in Italian Type 2 diabetic individuals.
• Environmental factors, such as adherence to a healthier diet common in the Italian population, may attenuate the impact of APOE mutations on mortality risk.